Skip to main content
. 2015 Jan 22;112(5):857–865. doi: 10.1038/bjc.2015.5

Figure 2.

Figure 2

Effect of OATP1B3 tumour expression on progression-free survival in patients treated with CPT-11-based chemotherapy regimen. (A) Pathology score of OATP1B3 expression in paired samples of normal, normal adjacent, and tumour tissue (n=30). (B) Association between OATP1B3 tumour score and progression-free survival in patients. (C) Representative immunohistochemistry of OATP1B3 expression in normal and tumour colon tissue. *<0.05.